Who Paid My Doc
PhIII Yellowstone Induction Study # 1 OZANIMOD in Moderate to Severe CD (RPC01-3201) (BMS Study Number: IM047-P14) (RPC01-3201)
Research payments
$1,301,117
Through program year 2019, $1,301,117 in research payments was reported against PhIII Yellowstone Induction Study # 1 OZANIMOD in Moderate to Severe CD (RPC01-3201) (BMS Study Number: IM047-P14) (RPC01-3201), across 127 payments, paid by Celgene Corporation.
- Paid by
- Celgene Corporation
- ClinicalTrials.gov
- No trial number was reported for this study
By program year
1 row| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2019 | Research | $1,301,117 | 127 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
10 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- Albert Diaz-Ordaz Orchard Park, NY Named on 2 payments
- Shankar Thiruppathi Columbus, GA Named on 2 payments
- Jeffery Lewis Atlanta, GA Named on 2 payments
- Parakkal Deepak Saint Louis, MO Named on 2 payments
- Bret Lashner Cleveland, OH Named on 2 payments
- Eugene Greenberg Urbana, IL Named on 2 payments
- Zeid Kayali Los Angeles, CA Named on 2 payments
- Jessica Ravikoff Boston, MA Named on 2 payments
- Zahid Rashid Petersburg, VA Named on 2 payments
- Randy Longman New York, NY Named on 2 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.